DJ Vertex Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ dropped 0.86% to $392.81 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 1.57% to 5,035.69 and Dow Jones Industrial Average falling 1.49% to 37,815.92.
This was the stock's fifth consecutive day of losses.
Vertex Pharmaceuticals Inc. closed $55.59 short of its 52-week high ($448.40), which the company reached on January 30th.
The stock demonstrated a mixed performance when compared to some of its competitors Tuesday, as AbbVie Inc. $(ABBV)$ rose 0.69% to $162.64, Krystal Biotech Inc. (KRYS) fell 3.08% to $153.12, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ fell 3.98% to $25.57.
Trading volume (1.7 M) eclipsed its 50-day average volume of 979,405.
Data source: Dow Jones Market Data, FactSet. Data compiled April 30, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 30, 2024 16:42 ET (20:42 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments